Frontlight ResearchEarly access
Parkinson disease trials in United States
228 of 294 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking people18F-mFBG Cardiac Uptake With Lewy Body Dementia
- Where
- Houston
- Age
- 18 years and over
- People
- 20
- Run by
- Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
See details and how to joinNCT07176286 - Phase 4Taking peopleBehavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
- Where
- Decatur, Philadelphia, Salt Lake City
- Age
- 18 years and over
- People
- 146
- Run by
- VA Office of Research and Development
See details and how to joinNCT07187466 - Phase 1Taking peopleUsing taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
- Where
- Birmingham
- Age
- 18 years to 80 years
- People
- 24
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07557706 - Phase 2Taking peopleStudy to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
- Where
- Boca Raton
- Age
- 40 years to 85 years
- People
- 474 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07781644 · EU 2025-524064-37-00 - No phaseTaking peopleNeocortical Microarchitecture of Executive Function
- Where
- Aurora
- Age
- 45 years to 85 years
- People
- 15
- Run by
- University of Colorado, Denver
See details and how to joinNCT06778135 - Phase 1/2Taking peoplePhase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
- Where
- Ann Arbor
- Age
- 45 years and over
- People
- 45
- Run by
- Prabesh Kanel
See details and how to joinNCT07154511 - Phase 2Taking peopleA Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
- Where
- Boca Raton, Farmington, Round Rock
- Age
- 40 years to 85 years
- People
- 150 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT07514858 · EU 2025-524655-30-00 - No phaseTaking peopleAdaptango Performance PRocess for Older Adults Community reHabilitation
- Where
- Atlanta
- Age
- 18 years and over
- People
- 120
- Run by
- Emory University
See details and how to joinNCT07824128 - No phaseTaking peopleDeep Brain Stimulation Surgery for Movement Disorders
- Where
- Bethesda
- Age
- 18 years to 99 years
- People
- 200
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT01581580 - No phaseTaking peopleDeep Brain Stimulation Therapy in Movement Disorders
- Where
- Bethesda
- Age
- 18 years to 100 years
- People
- 300
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT02119611 - No phaseEnrolling by invitationClosed Loop DBS Implanted RC+S Study
- Where
- Durham
- Age
- 18 years to 75 years
- People
- 46
- Run by
- Dennis Turner, M.D.
See details and how to joinNCT03815656 - No phaseTaking peopleStimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
- Where
- Pittsburgh
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Jorge Gonzalez-Martinez
See details and how to joinNCT07056361 - Phase 1Taking peopleSAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Where
- Englewood, Farmington Hills, Hallandale, Maitland, Spokane
- Age
- 40 years to 80 years
- People
- 40 worldwide
- Run by
- Serina Therapeutics
See details and how to joinNCT07422675 - No phaseNot yet taking people in United StatesCnF-DBS for Levodopa-Resistant FOG
- Where
- Miami, Philadelphia, San Francisco
- Age
- 35 years to 80 years
- People
- 18
- Run by
- Iahn Cajigas
See details and how to joinNCT07781696 - Phase 2Taking peopleRE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Austin, Birmingham, Boston, Buffalo, Chapel Hill, Charlottesville, Chicago, Cleveland, Columbus, Draper, Honolulu, Kansas City, Knoxville, Madison, New York, Novi, Omaha, Philadelphia, Rockville, San Diego, Santa Rosa, Seattle, Shreveport, Tampa, Towson, Tucson, Worcester
- Age
- 18 years to 80 years
- People
- 100
- Run by
- Reunion Neuroscience Inc
See details and how to joinNCT07002034 - Phase 2Taking peopleA Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Where
- Albuquerque, Altamonte Springs, Amherst, Arlington, Atlanta, Aventura, Baltimore, Canton, Cypress, Dallas, Decatur, Farmington Hills, Kirkland, Memphis, Miami, Murrieta, Naples, New York, Olney, Overland Park, Palm Beach, Patchogue, Raleigh, Round Rock, Scottsdale, Spokane, Stamford, Tampa
- Age
- 18 years to 65 years
- People
- 80 worldwide
- Run by
- Vima Therapeutics
See details and how to joinNCT07804615 - Phase 1/2Not yet taking people in United StatesA Phase 1/2a Clinical Study of KL002 in Treatment of Parkinson's Disease
- Where
- Houston
- Age
- 40 years to 75 years
- People
- 12
- Run by
- Kanglin Biotechnology (Hangzhou) Co., Ltd.
See details and how to joinNCT07929480 - Phase 2Taking peopleAn Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
- Where
- Atlanta, Aurora, Baltimore, Boca Raton, Boston, Charleston, Las Vegas, Lebanon, Los Angeles, Minneapolis, New York, North Haven, Philadelphia, Portland, San Antonio, St Louis
- Age
- 50 years to 80 years
- People
- 108 worldwide
- Run by
- Yale University
See details and how to joinNCT06996652 - No phaseNot yet taking people in United StatesEvaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
- Where
- Pomona
- Age
- 18 years and over
- People
- 20
- Run by
- Casa Colina Hospital and Centers for Healthcare
See details and how to joinNCT07923201 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Where
- Albuquerque, Amherst, Asheville, Atlanta, Atlantis, Birmingham, Boca Raton, Boston, Burlington, Canton, Charlottesville, Chicago, Cleveland, Commack, Dallas, Durham, Englewood, Farmington Hills, Fullerton, Honolulu, Kansas City, Lady Lake, La Jolla, Las Vegas, Los Angeles, Maitland, Memphis, Miami, Morgantown, Nashville, New Haven, New York, Orlando, Palo Alto, Paramus, Pasadena, Philadelphia, Phoenix, Pittsburgh, Portland, Reno, Richmond, Round Rock, San Francisco, Sioux Falls, Stanford, St Louis, Tampa, Tulsa, Washington D.C.
- Age
- 50 years to 85 years
- People
- 900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00 - No phaseTaking peopleAccelerated rTMS for Apathy in Parkinson's Disease
- Where
- Charleston
- Age
- 45 years to 85 years
- People
- 30
- Run by
- Medical University of South Carolina
See details and how to joinNCT07399496 - Phase 1/2Taking peopleTributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
- Where
- Ann Arbor
- Age
- 45 years and over
- People
- 15
- Run by
- Prabesh Kanel
See details and how to joinNCT07863180 - Phase 1Not yet taking people in United StatesAAV2-hAADC for Parkinson's Disease (PDCS-01)
- Where
- Columbus
- Age
- 18 years to 75 years
- People
- 9
- Run by
- Russell Lonser
See details and how to joinNCT07267065 - No phaseEnrolling by invitationTreatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation
- Where
- Richardson
- Age
- 50 years to 90 years
- People
- 20
- Run by
- The University of Texas at Dallas
See details and how to joinNCT07534397 - Phase 1Not yet taking people in United StatesStanford University Neurofiber Study
- Where
- Stanford
- Age
- 18 years and over
- People
- 50
- Run by
- Stanford University
See details and how to joinNCT07914387